Guidelines for public database submission of uncultivated virus genome sequences for taxonomic classification
The authors thank Anya Crane /National Institutes of Health , Fort Detrick, Frederick, MD, USA) for critically editing the manuscript.
Institute of Biodiversity, Faculty of Biological Sciences, Cluster of Excellence Balance of the Microverse, Friedrich Schiller University Jena, Jena, GermanyDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USAMatthew B. Sullivan Department of Civil, Environmental and Geodetic Engineering, The Ohio State University, Columbus, OH, USAMatthew B. SullivanRobert A.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mechanical waves identify the amputation position during wound healing in the amputated zebrafish tailfin - Nature PhysicsIt is known that mechanical waves play a role in collective motion in vitro. Now these waves can help an amputated zebrafish know where its fin was cut off to aid regeneration.
Read more »
Using gut microorganisms to treat cancer - Nature MedicineStrategies to monitor and modulate gut microorganisms to improve immunity and responses to cancer immunotherapy are increasingly available, with opportunities to expand and iterate on these approaches to treat, intercept and prevent cancer (and other diseases) altogether.
Read more »
Melting curve of superionic ammonia at planetary interior conditions - Nature PhysicsLaser-driven shock compression experiments yield the melting curve of the superionic phase of ammonia at conditions relevant to the interiors of Uranus and Neptune.
Read more »
Younger women advised to get mammograms at age 40 but questions remain about how oftenThe updated guidelines recommend that women at average risk for breast cancer begin mammograms at age 40 — a decade earlier than the previous guidelines — and continue every other year until age 74.
Read more »
Apogee Therapeutics sets IPO terms, to be valued at up to $774.5 mlnApogee Therapeutics Inc. has set terms for its initial public offering, as the Massachusetts-based biotechnology company developing treatments for chronic...
Read more »
Nanobiotix’s stock soars after entering licensing, development deal with J&J’s Janssen PharmaceuticaShares of Nanobiotix SA shot up 52.1% toward a 17-month high in premarket trading Monday, after the France-based biotechnology company announced a global...
Read more »